Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
RFK Jr. guts the US childhood vaccine schedule despite its decades-long safety record06.01.2026 - 2Get To Be familiar with The Historical backdrop Of Western Medication30.06.2023
- 3The most effective method to Shake Hands During a Pandemic: Wellbeing Tips and Behavior19.10.2023
- 4Nuno Loureiro, MIT physicist, fatally shot at home; police investigate17.12.2025
- 5Figure out How to Get a good deal on Your Rooftop Substitution Venture17.10.2023
- New law puts familiar drinks, creams and gummies in legal limbo
- Russia accidentally destroys its only way of sending astronauts to space
- Pick Your Favored kind of sandwich
- Turkiye’s Erdogan calls Israel’s Somaliland recognition ‘unacceptable’
- RFK Jr.'s diet guidelines emphasize red meat, full-fat dairy. How healthy are they?
- AI is providing emotional support for employees – but is it a valuable tool or privacy threat?
- The most effective method to Decisively Plan Your Nursing Profession for the Best Compensation Results
- Rocket Lab launches mystery satellite for 'confidential commercial customer' (video)
- California is completely free of drought for the first time in 25 years
